{"nct_id":"NCT04038437","title":"A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AML","status":"COMPLETED","status_verified_date":"2022-11","start_date":"2019-10-15","start_date_type":"ACTUAL","primary_completion_date":"2022-04-26","primary_completion_date_type":"ACTUAL","completion_date":"2022-09-24","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["JAZZ"]}